http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016003320-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6f8c0bba013eeddfc58666af97079de http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1128c13c17777ddc09695bc50e3ca1f5 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2015-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_133491f023ab8f0776840b05cfb6a69f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a9e577ce0e3b0ba323c9c1b3c2d2e3f |
| publicationDate | 2016-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2016003320-A1 |
| titleOfInvention | Method for treating patients having cancerous skin diseases (variants) |
| abstract | The invention relates to the field of medicine. Treating patients having cancerous skin diseases involves determining the size of a tumor and carrying out intradermal injections around the center of the damaged tissue prior to and/or following tumor removal, or directly into the tumor tissue, using a solution of a protein-polypeptide complex in a pharmaceutically acceptable carrier containing 0.05-0.4 mg of the complex. The protein-polypeptide complex is produced from a homogenate of embryonic nerve and skin tissues of hoofed farm animals. The protein-polypeptide complex contains proteins and polypeptides having a molecular weight of between 5 and 200 kDa, with a fraction having an average molecular weight of between 10 and 120 kDa constituting at least 80%; the total protein concentration is between 0.2 and 4.2 mg/ml, with maximum absorption of the UV spectrum of the solution happening at wavelengths of 280+5 nm, with a peak existing at a wavelength of 274-284 nm in the UV visible portion of the spectrum, with specific bands existing in a pi value interval from 4.2 to 8.4 during isoelectric focusing in a 5% polyacrylamide gel. A skin cancer treatment method involves using the protein-polypeptide complex externally in the form of applications, and as a course of preventive skin cancer treatment, using the protein-polypeptide complex in the form of creams, gels, and photoprotective compositions. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11161026-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11717737-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10603570-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10391381-B2 |
| priorityDate | 2014-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.